U.S. federal trademark · Serial No. 86755540 · Reg. No. 5481440
Pharmaceutical preparations for the prevention and treatment of cancer, inflammation and inflammatory diseases, auto-immune diseases, ophthalmic diseases, angiogenesis-dependent diseases, ocular angiogenic disease, diabetic retinopathy and macular degeneration made in whole or significant part of tyrosine kinase inhibitors
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.